ASEAN Pharma Report: Opportunities & Threats 2020 and …

ASEAN Pharma Report: Opportunities & Threats 2020 and Beyond CPhI South East Asia Report (1-3 July 2020). Overview Aging populations are transforming pharmaceutical To emphasize the size of the opportunity, within the markets in Southeast Asia. Growing healthcare next decade over half of the world's middle class will live expenditures bring Opportunities for Pharma , as well as within a six-hour flight of Bangkok, in addition, free trade new complexities and challenges. Wider competition in agreements with Australia and New Zealand have further Pharma manufacturing across the region adds to the mix opened up the region's potential. creating a dynamic environment to which industry players must adapt. Annual revenue growth in the Southeast Asian pharmaceutical market is predicted to exceed 11%.

ASEAN Pharma Report CPhI South East Asia 4 Opportunities and threats 2020 and beyond Philippines The demand for healthcare in the Philippines is rapidly increasing for many of the same reasons as most other Southeast Asian countries. An aging population and greater incidence of lifestyle-related diseases coupled

Tags:

  Threats, Opportunities, Opportunities and threats

Information

Related search queries